Identification and development of a subtype-selective allosteric AKT inhibitor suitable for clinical development

Natalie Page, Mark Wappett, Colin R. O'Dowd, Martin O'Rourke, Gerald Gavory, Lixin Zhang, J. S. Shane Rountree, Linda Jordan, Oliver Barker, Hayley Gibson, Caroline Boyd, Stephanie Feutren-Burton, Estelle McLean, Graham Trevitt, Timothy Harrison*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

5 Citations (Scopus)
109 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Identification and development of a subtype-selective allosteric AKT inhibitor suitable for clinical development'. Together they form a unique fingerprint.

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science